Skip to main content
Equibles
ABCL $11.38 +3.74%
ABCL logo

ABCL · AbCellera Biologics Inc.

Track ABCL — free

Use ABCL with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ABCL

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$11.38 +0.41 (+3.74%) At close · Aug 14
Market Cap
$3.49B
Shares
306.61M
All earnings calls

Earnings call · FY2026 Q1

AbCellera Biologics Inc. Q1 FY2026 Earnings Call

AbCellera Biologics Inc. Q1 FY2026 Earnings Call

Concluded May 11, 2026
May 11, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
3 artifacts
Slides 24 8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $8.31M +96.3% YoY
Diluted EPS -$0.14
Net income -$43.16M

Research materials

Open the source you need; every reader stays inside this workspace.

Presentation 24 slides 8-K earnings release Filed May 11, 2026 10-Q report Filed May 11, 2026 Company webcastOpen the original investor-relations page

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Research Fees$8.12M +99.7% YoY
Licensing and Royalty Revenue$191,000 +14.4% YoY
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)